FDA approves Boehringer's Pradaxa

FDA approved an NDA from Boehringer Ingelheim GmbH (Ingelheim, Germany) for Pradaxa dabigatran to prevent stroke and blood clots in patients with abnormal heart rhythm (atrial fibrillation). The compa...